Cargando…

Magnitude of efficacy measurements in grass allergy immunotherapy trials is highly dependent on pollen exposure

BACKGROUND: The objective was to evaluate the association between grass pollen exposure, allergy symptoms and impact on measured treatment effect after grass sublingual immunotherapy (SLIT)-tablet treatment. METHODS: The association between grass pollen counts and total combined rhinoconjunctivitis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Durham, S R, Nelson, H S, Nolte, H, Bernstein, D I, Creticos, P S, Li, Z, Andersen, J S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314686/ https://www.ncbi.nlm.nih.gov/pubmed/24605984 http://dx.doi.org/10.1111/all.12373

Ejemplares similares

Magnitude of changes in patient symptom and medication scores in grass allergy immunotherapy trials: dependency on levels of pollen exposure
por: Nolte, Hendrik, et al.
Publicado: (2014)

The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children
por: Hébert, Jacques, et al.
Publicado: (2014)

Efficacy of Timothy grass allergy immunotherapy tablet (AIT) treatment in Canadian children and adults with grass pollen-induced allergic rhinoconjunctivitis (ARC)
por: Hebert, Jacques, et al.
Publicado: (2011)

161 Efficacy and Safety of 300IR 5-Grass Pollen Sublingual Allergen Immunotherapy Tablets in us Adults With Grass-Pollen Allergic Rhinoconjunctivitis
por: Cox, Linda, et al.
Publicado: (2012)

Efficacy and safety of MK-7243: a grass allergy sublingual immunotherapy tablet evaluated in Canadian adults and children
por: Hébert, Jacques, et al.
Publicado: (2014)

A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma
por: Murphy, Kevin, et al.
Publicado: (2013)

Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy
por: Zieglmayer, Petra, et al.
Publicado: (2016)

176 Sublingual Immunotherapy for Grass Pollen Allergy in Children: A Systematic Review and Meta-Analysis
por: Bryson, Rebecca
Publicado: (2012)

Plant Food Allergy Improvement after Grass Pollen Sublingual Immunotherapy: A Case Series
por: Furci, Fabiana, et al.
Publicado: (2021)

Efficacy and safety of standardized short ragweed sublingual immunotherapy tablet (SLIT-T) treatment in Canadian subjects with ragweed pollen-induced rhinitis with or without conjunctivitis
por: Blaiss, Michael, et al.
Publicado: (2014)

Linear Epitope Binding Patterns of Grass Pollen-Specific Antibodies in Allergy and in Response to Allergen-Specific Immunotherapy
por: Thörnqvist, Linnea, et al.
Publicado: (2022)

Management of Grass Pollen Allergy with 5-Grass Pollen Tablet: Results of a 2-Year Real-Life Study
por: Shah-Hosseini, Kija, et al.
Publicado: (2017)

Treatment of grass pollen allergy: focus on a standardized grass allergen extract – Grazax(®)
por: Calderón, Moisés, et al.
Publicado: (2008)

Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge
por: Scadding, G. W., et al.
Publicado: (2015)

Allergy immunotherapy prescribing trends for grass pollen-induced allergic rhinitis in Germany: a retrospective cohort analysis
por: McDonell, Amanda L., et al.
Publicado: (2015)

Two grass pollen tablets commercially available for allergy immunotherapy display different IgE epitope repertoires
por: Batard, Thierry, et al.
Publicado: (2019)

Induction of Bronchial Tolerance After 1 Cycle of Monophosphoryl-A-Adjuvanted Specific Immunotherapy in Children With Grass Pollen Allergies
por: Rosewich, Martin, et al.
Publicado: (2016)

Grass pollen allergy in children and adolescents-symptoms, health related quality of life and the value of pollen prognosis
por: Kiotseridis, Hampus, et al.
Publicado: (2013)

Differences in grass pollen allergen exposure across Australia
por: Beggs, Paul J., et al.
Publicado: (2015)

Chinese Birch Pollen Allergy and Immunotherapy in Mice
por: Xie, Zhijuan, et al.
Publicado: (2019)

Short-Term Exposure of Dactylis glomerata Pollen to Atmospheric Gaseous Pollutants Is Related to an Increase in IgE Binding in Patients with Grass Pollen Allergies
por: Fernández-González, María, et al.
Publicado: (2022)

Assessment of Google Trends terms reporting allergies and the grass pollen season in Ukraine
por: Kaidashev, Igor, et al.
Publicado: (2020)

Are Markers of Allergic Inflammation in Grass Pollen Allergy Influenced by H1 Antihistamines?
por: Bocsan, Ioana Corina, et al.
Publicado: (2021)

Exposure to grass pollen – but not birch pollen – affects lung function in Swedish children
por: Gruzieva, O., et al.
Publicado: (2015)

Evaluation of subcutaneous immunotherapy with birch pollen extract for pollen-food allergy syndrome
por: Hamada, Masaaki, et al.
Publicado: (2021)

Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis
por: Malling, H-J, et al.
Publicado: (2009)

Intradermal grass pollen immunotherapy increases T(H)2 and IgE responses and worsens respiratory allergic symptoms
por: Slovick, Anna, et al.
Publicado: (2017)

Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy
por: Focke-Tejkl, Margarete, et al.
Publicado: (2015)

Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection
por: Cornelius, Carolin, et al.
Publicado: (2016)

Efficiacy of injection specific immunotherapy for grass pollen seasonal allergic rhinitis
por: Wasilewska, Eliza, et al.
Publicado: (2015)

Safety and efficacy of immunotherapy with the recombinant B-cell epitope–based grass pollen vaccine BM32
por: Niederberger, Verena, et al.
Publicado: (2018)

A Multicenter, Randomized, Parallel-Group Trial Assessing Compliance, Tolerability, Safety, and Efficacy to Treatment with Grass Allergy Tablets in 261 Patients with Grass Pollen Rhinoconjunctivitis
por: Alesina, Roberta, et al.
Publicado: (2012)

Influence of seasonal exposure to grass pollen on local and peripheral blood IgE repertoires in patients with allergic rhinitis
por: Wu, Yu-Chang B., et al.
Publicado: (2014)

The role of short‐term grass pollen exposure in food skin‐prick test reactivity, food allergy, and eczema flares in children
por: Idrose, Nur Sabrina, et al.
Publicado: (2022)

Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis
por: Kim, Harold, et al.
Publicado: (2014)

Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis
por: Lombardi, Carlo, et al.
Publicado: (2017)

5-grass-pollen SLIT effectiveness in seasonal allergic rhinitis: Impact of sensitization to subtropical grass pollen
por: van Nunen, Sheryl A., et al.
Publicado: (2022)

An observational cohort study of the use of five-grass-pollen extract sublingual immunotherapy during the 2015 pollen season in France
por: Blin, Patrick, et al.
Publicado: (2018)

Allergy to grass pollen: mapping of Dactylis glomerata and Phleum pratense allergens for dogs by two-dimensional immunoblotting
por: Martins, Luís Miguel Lourenço, et al.
Publicado: (2017)

Subcutaneous Immunotherapy in Patients with Fagales Pollen-Induced Oral Allergy Syndrome
por: Kong, Nasil, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_64oh8kk0o5qb35knidmaubmd5m